Building on points developed in his 2020 PharmaBoardroom interview, Professor Nicolaus Kröger of the European Society for Blood and Marrow Transplantation (EBMT) outlines the progress made by the multi-stakeholder GoCART Coalition towards greater harmonisation of cell and gene therapy research in Europe, the challenges of integrating patient-reported outcomes into its registry, and his hopes for the future of the field.
I feel that CAR-T cells are just the beginning of cell and gene therapy and foresee massive expansion in the next few years for which collaboration is essential
